Cargando…

A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis

Classification of acute lymphoblastic and myeloid leukemias (ALL and AML) remains heavily based on phenotypic resemblance to normal hematopoietic precursors. This framework can provide diagnostic challenges for immunophenotypically heterogeneous immature leukemias, and ignores recent advances in und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bond, Jonathan, Krzywon, Aleksandra, Lhermitte, Ludovic, Roumier, Christophe, Roggy, Anne, Belhocine, Mohamed, Kheirallah, Alexander Abdulkader, Villarese, Patrick, Hypolite, Guillaume, Garnache-Ottou, Francine, Castaigne, Sylvie, Boissel, Nicolas, Asnafi, Vahid, Preudhomme, Claude, Dombret, Hervé, Laurenti, Elisa, Macintyre, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932917/ https://www.ncbi.nlm.nih.gov/pubmed/32655144 http://dx.doi.org/10.1038/s41375-020-0965-z

Ejemplares similares

Targeting IRAK1 in T-Cell acute lymphoblastic leukemia
por: Dussiau, Charles, et al.
Publicado: (2015)

Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia
por: Touzart, Aurore, et al.
Publicado: (2020)

DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia
por: Bond, Jonathan, et al.
Publicado: (2019)

TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
por: Balducci, Estelle, et al.
Publicado: (2023)

Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment
por: Fenwarth, Laurène, et al.
Publicado: (2020)

Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms
por: Roussel, Xavier, et al.
Publicado: (2022)

Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL
por: Dourthe, Marie Emilie, et al.
Publicado: (2023)

Case Report: Evolution of a Severe Vascular Refractory Form of ECD Requiring Liver Transplantation Correlated With the Change in the Monocyte Subset Analysis
por: Razanamahery, Jérôme, et al.
Publicado: (2021)

Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins
por: Steimlé, Thomas, et al.
Publicado: (2022)

Lymphoblastic T Cells and Mature NK Cells With the Same TCRγ Rearrangement: A Common Origin?
por: Roggy, Anne, et al.
Publicado: (2021)

Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
por: Simonin, Mathieu, et al.
Publicado: (2021)

Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL
por: Smith, Charlotte, et al.
Publicado: (2023)

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
por: Debarri, Houria, et al.
Publicado: (2015)

Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group
por: Ferret, Yann, et al.
Publicado: (2018)

RUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangement
por: Cieslak, Agata, et al.
Publicado: (2014)

RUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangement
por: Cieslak, Agata, et al.
Publicado: (2014)

Blueprint of human thymopoiesis reveals molecular mechanisms of stage-specific TCR enhancer activation
por: Cieslak, Agata, et al.
Publicado: (2020)

Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial
por: Renneville, Aline, et al.
Publicado: (2014)

S106: METABOLIC PLASTICITY REVEALS A TARGETABLE VULNERABILITY IN LEUKEMIA
por: Andrieu, Guillaume, et al.
Publicado: (2023)

P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
por: Dourthe, Marie-Emilie, et al.
Publicado: (2023)

MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin
por: Lambert, Juliette, et al.
Publicado: (2014)

Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2015)

Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
por: Lambert, Juliette, et al.
Publicado: (2021)

Oncogenetic landscape of lymphomagenesis in coeliac disease
por: Cording, Sascha, et al.
Publicado: (2022)

SNP-array lesions in core binding factor acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2018)

Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients
por: Zver, Tristan, et al.
Publicado: (2022)

P319: IL7-RECEPTOR EXPRESSION IS FREQUENT IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND PREDICTS SENSITIVITY TO JAK-INHIBITION
por: Courtois, Lucien, et al.
Publicado: (2023)

Toward Pediatric T Lymphoblastic Lymphoma Stratification Based on Minimal Disseminated Disease and NOTCH1/FBXW7 Status
por: Trinquand, Amélie, et al.
Publicado: (2021)

Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia
por: Cornet, Edouard, et al.
Publicado: (2014)

The oncogenetic landscape and clinical impact of BCL11B alterations in adult and pediatric T-cell acute lymphoblastic leukemia
por: Dourthe, Marie Emilie, et al.
Publicado: (2023)

P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN
por: Veleanu, Layla, et al.
Publicado: (2023)

A hierarchical approach in the diagnostic workflow of chronic myelomonocytic leukemia: Pivotal role of the “Mono‐dysplasia‐score” combined with flow cytometric quantification of monocyte subsets
por: Zhu, Jaja, et al.
Publicado: (2019)

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial
por: Lambert, Juliette, et al.
Publicado: (2019)

Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients
por: Balducci, Estelle, et al.
Publicado: (2022)

Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia
por: Callens, Celine, et al.
Publicado: (2010)

Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies
por: Magne, Julien, et al.
Publicado: (2018)

Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
por: Philippe, Laure, et al.
Publicado: (2017)

B7‐H3 protein expression in acute myeloid leukemia
por: Guery, Thomas, et al.
Publicado: (2015)

Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia
por: Bond, Jonathan, et al.
Publicado: (2016)

Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study
por: Boyer, Thomas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qjuq5j3bt0n5prcbflcj2m5nsm